التهاب الفقار اللاصق مع التهاب المفاصل المحيطية: ما الذي يجب فعله عندما لا يحقق العلاج الحيوي أو مثبطات كيناز جانوس استجابةً كافية

References

DOI: 10.1136/ard-2022-223296

Patients with purely axial disease should normally not be treated with csDMARDs; sulfasalazine may be considered in patients with peripheral arthritis.

In patients with predominantly peripheral manifestations, following recommendations 7 and 8, failure to treatment includes one glucocorticoid injection, if appropriate, and the use of sulfasalazine.

Total hip arthroplasty should be considered in patients with refractory pain or disability and radiographic evidence of structural damage, independent of age; spinal corrective osteotomy in specialised centres may be considered in patients with severe disabling deformity.